Carpenter D. “Reputation Information and Confidence – The Political Economy of Pharmaceutical Regulation” . Public Choice and Public Law . 2010.

Carpenter D, Keyhani S, Anderson G, Hebert P, Wang S. “U.S. Pharmaceutical Innovation in an International Context” . American Journal of Public Health [Internet]. 2010;(6):1075-1080. Website

Carpenter D, Moffitt S, Moore C, Rynbrandt R, Ting M, Yohai I, Zucker EJ. “Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review”. Journal of Law Economics and Organization . 2010;26(2).

“Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration” . Perspective on Politics. 2010;8(3):825-46.

Carpenter D, Grimmer J, Lomazoff E. “Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation” . Regulation and Governance . 2010;4(4).

Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton: Princeton University Press; 2010. Website